Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation — Wern Yew Ding (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Shared by
Professor Gregory Lip
University of Liverpool
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Article
2022
en
Authors
+4 more
WD
Wern Yew Ding
JR
José Miguel Rivera‐Caravaca
EF
Elnara Fazio‐Eynullayeva
Abstract
1 min read
Overall, LAA occlusion might be a suitable alternative to NOAC therapy for stroke prevention in patients with AF.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
Wern Yew Ding
,
Professor Gregory Lip
,
Timothy Fairbairn
,
Sukumaran Binukrishnan
,
Afshin Khalatbari
,
Periaswamy Velavan
,
Dhiraj Gupta
Article
2019
P4758Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study
Hee Tae Yu
,
Pil‐Sung Yang
,
Eunsun Jang
,
Tae‐Hoon Kim
,
Jae‐Sun Uhm
,
Jong‐Youn Kim
,
Hui‐Nam Pak
,
M H Lee
,
Boyoung Joung
,
Professor Gregory Lip
Article
2019
P4780Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease
Inki Moon
,
S R Lee
,
Eunsuk Choi
,
E J Lee
,
Jin‐Hyung Jung
,
Kyungdo Han
,
M J
,
Seil Oh
,
Professor Gregory Lip
Article
2020
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
Hans‐Christoph Diener
,
Graeme J. Hankey
,
J. Donald Easton
,
Professor Gregory Lip
,
Robert G. Hart
,
Valeria Caso
Letter
2021
Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the ‘transition era’ to non-vitamin K antagonist oral anticoagulants
Leona A. Ritchie
,
Deirdre A. Lane
,
Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.